Angiotensin Receptor Antagonists Concept

subject area of

• 24-h ambulatory blood pressure readings and associations with albuminuria in youth with type 2 diabetes: A cross sectional analysis from the iCARE cohort  Journal Articles
• AT ₁ Receptor Antagonist Treatment Caused Persistent Arterial Functional Changes in Young Spontaneously Hypertensive Rats  Journal Articles
• Acute Kidney Injury in Patients Receiving Systemic Treatment for Cancer: A Population-Based Cohort Study  Journal Articles
• Albuminuria and Decline in Cognitive Function<subtitle>The ONTARGET/TRANSCEND Studies</subtitle><alt-title>Albuminuria and Decline in Cognitive Function</alt-title>  Journal Articles
• Analysis of Outcomes in Ischemic vs Nonischemic Cardiomyopathy in Patients With Atrial Fibrillation  Journal Articles
• Angiotensin Blockade Modulates the Activity of PD1/L1 Inhibitors in Metastatic Urothelial Carcinoma  Journal Articles
• Angiotensin receptor blocker therapy and risk of cancer  Journal Articles
• Angiotensin receptor blockers in heart failure: meta-analysis of randomized controlled trials  Journal Articles
• Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in atherosclerosis  Journal Articles
• Angiotensin-converting enzyme inhibitors or angiotensin receptor blockers are beneficial in normotensive atherosclerotic patients: a collaborative meta-analysis of randomized trials  Journal Articles
• Angiotensin-receptor blockers in prevention of cardiovascular events: are they as effective as angiotensin-converting enzyme inhibitors?  Journal Articles
• Antihypertensive Drug Prescribing and Persistence Among New Elderly Users: Implications for Persistence Improvement Interventions  Journal Articles
• Antihypertensive treatment and risk of cancer: an individual participant data meta-analysis  Journal Articles
• Association between angiotensin converting enzyme inhibitor or angiotensin receptor blocker use prior to major elective surgery and the risk of acute dialysis  Journal Articles
• Association of Acute Increases in Plasma Creatinine after Renin-Angiotensin Blockade with Subsequent Outcomes  Journal Articles
• Blockade of the renin–angiotensin–aldosterone system (RAAS) for primary prevention of non-valvular atrial fibrillation: A systematic review and meta analysis of randomized controlled trials  Journal Articles
• Blood pressure lowering and risk of new-onset type 2 diabetes: an individual participant data meta-analysis  Journal Articles
• CCS/CHFS Heart Failure Guidelines: Clinical Trial Update on Functional Mitral Regurgitation, SGLT2 Inhibitors, ARNI in HFpEF, and Tafamidis in Amyloidosis  Journal Articles
• Canadian Cardiovascular Society Guidelines for the Diagnosis and Management of Stable Ischemic Heart Disease  Journal Articles
• Canadian Cardiovascular Society Quality Indicators for Heart Failure  Journal Articles
• Candesartan in heart failure—assessment of reduction in mortality and morbidity (CHARM): Rationale and design  Journal Articles
• Cardiovascular and Renal Outcomes With Telmisartan, Ramipril, or Both in People at High Renal Risk  Journal Articles
• Cardiovascular and cerebrovascular outcomes of long-term angiotensin receptor blockade: meta-analyses of trials in essential hypertension  Journal Articles
• Clinical and pathological findings of SARS-CoV-2 infection and concurrent IgA nephropathy: a case report  Journal Articles
• Clinical trials, the renin angiotensin system and atrial fibrillation  Journal Articles
• Comparative Effectiveness of Renin-Angiotensin System Inhibitors and Calcium Channel Blockers in Individuals With Advanced CKD: A Nationwide Observational Cohort Study  Conferences
• Comparative Effects of Losartan and Enalapril on Exercise Capacity and Clinical Status in Patients With Heart Failure fn1fn1This study was supported by a grant from Merck Research Laboratories, West Point, Pennsylvania.  Journal Articles
• Comparative Efficacy of Angiotensin II Antagonists in Essential Hypertension: Systematic Review and Network Meta-Analysis of Randomised Controlled Trials  Journal Articles
• Comparative impact of enalapril, candesartan or metoprolol alone or in combination on ventricular remodelling in patients with congestive heart failure  Journal Articles
• Correction: Prospective Cohort Study of Renin-Angiotensin System Blocker Usage after Hospitalized Acute Kidney Injury  Journal Articles
• Covariate adjusted reanalysis of the I-Preserve trial  Journal Articles
• Cross-over study comparing effects of treatment with an angiotensin converting enzyme inhibitor and an angiotensin II type 1 receptor antagonist on cardiovascular changes in hypertension  Journal Articles
• Does Renin‐Angiotensin System Blockade Protect Lupus Nephritis Patients From Atherosclerotic Cardiovascular Events? A Case–Control Study  Journal Articles
• Effectiveness and risk of ARB and ACEi among different ethnic groups in England: A reference trial (ONTARGET) emulation analysis using UK Clinical Practice Research Datalink Aurum-linked data.  Journal Articles
• Effects of ACE inhibitors and angiotensin receptor blockers: protocol for a UK cohort study using routinely collected electronic health records with validation against the ONTARGET trial  Journal Articles
• Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial  Journal Articles
• Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function intolerant to angiotensin-converting-enzyme inhibitors: the CHARM-Alternative trial  Journal Articles
• Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors: the CHARM-Added trial  Journal Articles
• Effects of candesartan on mortality and morbidity in patients with chronic heart failure: the CHARM-Overall programme  Journal Articles
• Effects of different blood-pressure-lowering regimens on major cardiovascular events: results of prospectively-designed overviews of randomised trials  Journal Articles
• Effects of myocardial fibrosis and ventricular dyssynchrony on response to therapy in new-presentation idiopathic dilated cardiomyopathy: insights from cardiovascular magnetic resonance and echocardiography  Journal Articles
• Effects of withdrawing vs continuing renin-angiotensin blockers on incidence of acute kidney injury in patients with renal insufficiency undergoing cardiac catheterization: Results from the Angiotensin Converting Enzyme Inhibitor/Angiotensin Receptor Blocker and Contrast Induced Nephropathy in Patients Receiving Cardiac Catheterization (CAPTAIN) trial  Journal Articles
• Efficacy of angiotensin II receptor antagonists in preventing headache: a systematic overview and meta-analysis  Journal Articles
• Eligibility and Projected Benefits of Rapid Initiation of Quadruple Therapy for Newly Diagnosed Heart Failure  Journal Articles
• Empagliflozin in the treatment of heart failure with reduced ejection fraction in addition to background therapies and therapeutic combinations (EMPEROR-Reduced): a post-hoc analysis of a randomised, double-blind trial  Journal Articles
• From ACE Inhibitors/ARBs to ARNIs in Coronary Artery Disease and Heart Failure (Part 2/5)  Journal Articles
• From the hope to the ontarget and the transcend studies: challenges in improving prognosis  Journal Articles
• Guideline-Recommended Therapy Following Hospitalization for Heart Failure  Journal Articles
• HFSA guidelines for management of patients with heart failure caused by left ventricular systolic dysfunction—pharmacological approaches  Journal Articles
• HR 720, a novel angiotensin receptor antagonist inhibits the angiotensin II-induced trophic effects, fibronectin release and fibronectin-EIIIA+ expression in rat aortic vascular smooth muscle cells in vitro.  Journal Articles
• Heart failure.  Journal Articles
• Heart failure.  Journal Articles
• Heart failure.  Journal Articles
• Hiding in plain sight—wildlife as a neglected reservoir and pathway for the spread of antimicrobial resistance: a narrative review  Journal Articles
• Hyperkalemia-Related Discontinuation of Renin-Angiotensin-Aldosterone System Inhibitors and Clinical Outcomes in CKD: A Population-Based Cohort Study  Journal Articles
• Impact of Acarbose on Incident Diabetes and Regression to Normoglycemia in People With Coronary Heart Disease and Impaired Glucose Tolerance: Insights From the ACE Trial  Journal Articles
• Impact of Angiotensin Converting Enzyme Inhibitors on Pathologic Complete Response With Neoadjuvant Chemotherapy for Muscle Invasive Bladder Cancer  Journal Articles
• Impact of diabetes, angiotensin‐converting enzyme inhibitor or angiotensin II receptor blocker use, and statin use on presentation and outcomes in patients with giant cell arteritis  Conferences
• Initiation of sacubitril/valsartan in haemodynamically stabilised heart failure patients in hospital or early after discharge: primary results of the randomised TRANSITION study  Journal Articles
• Is there an optimal combination of antihypertensives for preventing cardiovascular events?  Journal Articles
• Kidney Function and Potassium Monitoring After Initiation of Renin-Angiotensin-Aldosterone System Blockade Therapy and Outcomes in 2 North American Populations  Journal Articles
• Length of Initial Prescription at Hospital Discharge and Long-term Medication Adherence for Elderly Patients With Coronary Artery Disease: A Population-Level Study  Journal Articles
• Meta-Analysis Comparing Neurohumoral Antagonist Use in Patients ≥75 Years Versus <75 Years Receiving Cardiac Resynchronization Therapy  Journal Articles
• Mineralocorticoid Receptor Antagonists in CKD: In Need of a Few Large Trials  Journal Articles
• No Increase in Adverse Events During Aliskiren Use Among Ontario Patients Receiving Angiotensin-Converting Enzyme Inhibitors or Angiotensin-Receptor Blockers  Journal Articles
• Patient Age, Ethnicity, Medical History, and Risk Factor Profile, but Not Drug Insurance Coverage, Predict Successful Attainment of Glycemic Targets  Journal Articles
• Pharmaco‐disparities in heart failure: a survey of the affordability of guideline recommended therapy in 10 countries  Journal Articles
• Polypharmacy and Optimization of Guideline-Directed Medical Therapy in Heart Failure  Journal Articles
• Practical recommendations for the use of ACE inhibitors, beta‐blockers, aldosterone antagonists and angiotensin receptor blockers in heart failure: Putting guidelines into practice  Journal Articles
• Preoperative angiotensin-converting enzyme inhibitors and angiotensin receptor blocker use and acute kidney injury in patients undergoing cardiac surgery  Journal Articles
• Prevention of Atrial Fibrillation With Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers  Journal Articles
• Prospective Cohort Study of Renin-Angiotensin System Blocker Usage after Hospitalized Acute Kidney Injury  Journal Articles
• Recent advances in the drug treatment of heart failure  Journal Articles
• Receptor subtypes mediating spinal cardiovascular effects of angiotensin II in rat using losartan and PD 123319  Journal Articles
• Renin-angiotensin system blockade and cognitive function in patients at high risk of cardiovascular disease: analysis of data from the ONTARGET and TRANSCEND studies  Journal Articles
• Revisiting Race and the Benefit of RAS Blockade in Heart Failure  Journal Articles
• Risk Factors, Use of Preventive Drugs, and Cardiovascular Events in Diabetes Mellitus: The PURE Türkiye Cohort  Journal Articles
• Risk of Hospitalization for Community Acquired Pneumonia with Renin-Angiotensin Blockade in Elderly Patients: A Population-Based Study  Journal Articles
• Role of Renin-Angiotensin System Blockade in Atherosclerotic Renal Artery Stenosis and Renovascular Hypertension  Journal Articles
• Role of the renin-angiotensin-aldosterone system in atrial fibrillation and cardiac remodeling.  Journal Articles
• Sex Disparities in Longitudinal Use and Intensification of Guideline-Directed Medical Therapy Among Patients With Newly Diagnosed Heart Failure With Reduced Ejection Fraction  Journal Articles
• Slowly inactivating potassium conductance (I(D)): a potential target for stroke therapy.  Journal Articles
• Stopping Renin-Angiotensin System Inhibitors in Patients with Advanced CKD and Risk of Adverse Outcomes: A Nationwide Study  Journal Articles
• Stopping renin-angiotensin system blockers after acute kidney injury and risk of adverse outcomes: parallel population-based cohort studies in English and Swedish routine care  Journal Articles
• Stopping renin-angiotensin system inhibitors after hyperkalemia and risk of adverse outcomes  Journal Articles
• The 2001 Canadian Cardiovascular Society consensus guideline update for the management and prevention of heart failure.  Journal Articles
• The 2014 Canadian Cardiovascular Society Heart Failure Management Guidelines Focus Update: Anemia, Biomarkers, and Recent Therapeutic Trial Implications  Journal Articles
• The Role of Angiotensin II Receptor Blockers in the Treatment of Heart Failure Patients  Journal Articles
• The therapeutic potential of angiotensin II receptor blockers in the treatment of heart failure  Journal Articles
• Underutilization of Guideline-Directed Medical Therapy in Heart Failure  Journal Articles
• Use of Angiotensin-Converting Enzyme Inhibitors or Angiotensin Receptor Blockers and Cardiovascular Outcomes in Chronic Dialysis Patients: A Population-Based Cohort Study  Journal Articles
• Valsartan, Captopril, or Both in Myocardial Infarction Complicated by Heart Failure, Left Ventricular Dysfunction, or Both  Journal Articles
• Withholding versus Continuing Angiotensin-converting Enzyme Inhibitors or Angiotensin II Receptor Blockers before Noncardiac Surgery  Journal Articles
• Worsening renal function and outcome in heart failure patients with reduced and preserved ejection fraction and the impact of angiotensin receptor blocker treatment: data from the CHARM‐study programme  Journal Articles